SQSTM1 and lip and oral cavity carcinoma: In this study we discovered an association between p62/SQSTM1 excess and poor clinical survival, and we propose that p62/SQSTM1 may be a potential novel predictive biomarker in the chemo-radiotherapeutic management of oral carcinoma cases.